Schizophrenia (SZ) is often described as a disease of neuronal connectivity. Cognitive processes such as working memory, which are particularly dependent on the proper functioning of complex cortical circuitry, are disturbed in the disease. Reciprocal connections between pyramidal neurons and interneurons, as well as dopaminergic innervations, form the basis for higher cognition in the cortex. Nonetheless, only a few review articles are available which address how each synapse operates, and is possibly disturbed in SZ, at least in part by the mechanisms involving genetic susceptibility factors for SZ. In this review, we provide an overview of cortical glutamatergic, GABAergic, and dopaminergic circuitry, review SZ-associated deficits at each of these synapses, and discuss how genetic factors for SZ may contribute to SZ-related phenotype deficits in a synapse-specific manner. Pinpointing the spatially and temporally distinct sites of action of putative SZ susceptibility factors may help us better understand the pathological mechanisms of SZ, especially those associated with synaptic functioning and neuronal connectivity.
Introduction
Disturbances in neuronal connectivity are frequently thought to be a key pathology associated with schizophrenia (SZ) (Hayashi-Takagi and Sawa, 2010) . At the neuroanatomical level, SZ patients exhibit reductions in frontal gray matter volume, mainly shown by magnetic resonance imaging (MRI), and in structural integrity of cortico-cortical white matter tracts, shown by diffusion tensor imaging (DTI) (Glahn et al., 2008; Honea et al., 2005; Mathalon et al., 2001; Phillips et al., 2011) . At the clinico-physiological level, deficits in cortical synchrony (particularly in gamma-band oscillations, which are brought about by functional connectivity of excitatory and inhibitory neurons) have been found in the prefrontal cortex of SZ patients (Farzan et al., 2010; Lee et al., 2003) . At the cellular level, a number of postmortem studies in SZ brains point to cytoarchitectural and protein expression deficits which could contribute to altered excitatory-inhibitory balance in the disease. For example, reduced density of dendritic spines, which are excitatory synaptic structures on pyramidal neurons, has been reported in SZ patients (Garey, 2010; Glantz and Lewis, 2000; Kolluri et al., 2005) . Reduced mRNA expression of glutamic acid decarboxylase (GAD67), a synthetic enzyme for the inhibitory neurotransmitter GABA, is consistently observed in SZ patient brains (Akbarian et al., 1995; Knable et al., 2002) . In addition, studies of gene expression by microarray analysis show reduced expression of synapse-regulating proteins in SZ patient tissue (Horvath et al., 2011) . Neurobiology of Disease 53 (2013) 26-35 
